Synthesis and biological evaluation of 1,2,4-oxadiazole linked 1,3,4-oxadiazole derivatives as tubulin binding agents

References

• Rigo, B.; Couturier, D. Studies on Pyrrolidinones. Synthesis of 5-(5-Oxo-2-Pyrrolidinyl)-1,3,5-Oxadiazole-2-Thione Derivatives. J. Heterocycl. Chem. 1985, 22, 287. DOI 10.1002/jhet.5570220209
   Web of Science ®Google Scholar
• Yadav, M. R.; Shirude, S. T.; Puntambekar, D. S.; Patel, P. J.; Prajapati, H. B.; Parmar, A.; Balaraman, R.; Giridhar, R. Studies in 3,4-Diaryl-1,2,5-Oxadiazoles and Their N-Oxides: search for Better COX-2 Inhibitors. Acta Pharm. 2007, 57, 13. DOI 10.2478/v10007-007-0002-z
   PubMedGoogle Scholar
• Gaonkar, S. L.; Rai, K. M. L.; Prabhuswamy, B. Eur. J. Med. Chem. 2006, 41, 841. DOI 10.1016/j.ejmech.2006.03.002
   PubMed Web of Science ®Google Scholar
• Tan, T. M.; Chen, Y.; Kong, K. H.; Bai, J.; Li, Y.; Lim, S. G.; Ang, T. H.; Lam, Y. Synthesis and the Biological Evaluation of 2-Benzenesulfonylalkyl-5-Substituted-Sulfanyl-[1,3,4]-Oxadiazoles as Potential anti-Hepatitis B Virus Agents. Antivir. Res. 2006, 71, 7. DOI 10.1016/j.antiviral.2006.02.007
   PubMed Web of Science ®Google Scholar
• Li, Y.; Liu, J.; Zhang, H.; Yang, X.; Liu, Z. Stereoselective Synthesis and Fungicidal Activities of (E)-alpha-(methoxyimino)-benzeneacetate derivatives containing 1,3,4-oxadiazole ring. Bioorg. Med. Chem. Lett. 2006, 16, 2278. DOI 10.1016/j.bmcl.2006.01.026
   PubMed Web of Science ®Google Scholar
• Aboraia, A. S.; Rahman, H. M. A.; Mahfouz, N. M.; Gendy, M. A. Novel 5-(2-Hydroxyphenyl)-3-Substituted-2,3-Dihydro-1,3,4-Oxadiazole-2-Thione Derivatives: Promising Anticancer Agents. Bioorg. Med. Chem. Lett. 2006, 14, 1236. DOI 10.1016/j.bmc.2005.09.053
   Web of Science ®Google Scholar
• Khan, M. T.; Choudhary, M. I.; Khan, K. M.; Rani, M.; Rahman, A. U. Bioorg. Med. Chem. 2005, 13, 3385. DOI 10.1016/j.bmc.2005.03.012
   PubMed Web of Science ®Google Scholar
• Farshori, N. N.; Banday, M. R.; Ahmad, A.; Khan, A. U.; Rauf, A. Synthesis, Characterization, and In Vitro Antimicrobial Activities of 5-Alkenyl/Hydroxyalkenyl-2-Phenylamine-1,3,4-Oxadiazoles and Thiadiazoles. Bioorg. Med. Chem. Lett. 2010, 20, 1933. DOI 10.1016/j.bmcl.2010.01.126
   PubMed Web of Science ®Google Scholar
• Jayashankar, B.; Lokanath Rai, K. M.; Baskaran, N.; Sathish, H. S. Synthesis and Pharmacological Evaluation of 1,3,4-Oxadiazole Bearing Bis(Heterocycle) Derivatives as Anti-Inflammatory and Analgesic Agents. Eur. J. Med. Chem. 2009, 44, 3898. DOI 10.1016/j.ejmech.2009.04.006
   PubMed Web of Science ®Google Scholar
• Kucukguzel, S. G.; Oruc, E. E.; Rollas, S.; Sahin, F.; Ozbek, A. Synthesis, Characterisation and Biological Activity of Novel 4-Thiazolidinones, 1,3,4-Oxadiazoles and Some Related Compounds. Eur. J. Med. Chem. 2002, 37, 197. DOI 10.1016/S0223-5234(01)01326-5
   PubMed Web of Science ®Google Scholar
• Husain, A.; Ajmal, M. Synthesis of Novel 1,3,4-Oxadiazole Derivatives and their Biological Properties. Acta Pharm. 2009, 59, 223. doi:10.2478/v10007-009-0011-1
   PubMed Web of Science ®Google Scholar
• Savarino, A. A Historical Sketch of the Discovery and Development of HIV-1 Integrase inhibitors. Expert Opin. Investig. Drugs. 2006, 15, 1507–1522. DOI 10.1517/13543784.15.12.1507
   PubMed Web of Science ®Google Scholar
• James, N. D.; Growcott, J. W. Zibotentan. Drugs Fut. 2009, 34, 624–633. DOI 10.1358/dof.2009.034.08.1400202
   Web of Science ®Google Scholar
• Clapp, L. B.; Katritzky, A. R.; Rees, C. W. In Comprehensive Heterocyclic Chemistry (Eds.); Pergamom Press: Oxford, 1984; Vol. 6; pp. 365.
   Google Scholar
• Vu, C. B.; Corpuz, E. G.; Merry, T. J.; Pradeepan, S. G.; Bartlett, C.; Bohacek, R. S.; Botfield, M. C.; Lynch, B. A.; MacNeil, I. A.; Ram, M. K.; et al. Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70. J. Med. Chem. 1999, 42, 4088–4098. DOI 10.1021/jm990229t
   PubMed Web of Science ®Google Scholar
• Luthman, K.; Borg, S.; Hacksell, O. Synthesis and Use of Pseudopeptides Derived from 1,2,4-Oxadiazole-, 1,3,4-Oxadiazole-, and 1,2,4-Triazole-Based Dipeptidomimetics. Methods Mol. Med. 1999, 23, 123.
   Google Scholar
• Andersen, K. E.; Jørgensen, A. S.; Braestrup, C. Oxadiazoles as Bioisosteric Transformations of Carboxylic Functionalities. Part I. Eur. J. Med. Chem. 1994, 29, 393–399. DOI 10.1016/0223-5234(94)90065-5
   Web of Science ®Google Scholar
• Ispikoudi, M.; Amvrazis, M.; Kontogiorgis, C.; Koumbis, A. E.; Litinas, K. E.; Hadjipavlou-Litina, D.; Fylaktakidou, K. C. Convenient Synthesis and Biological Profile of 5-amino-substituted 1,2,4-oxadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5635–5645. DOI 10.1016/j.ejmech.2010.09.016
   PubMed Web of Science ®Google Scholar
• Bokach, N. A.; Khripoun, A. V.; Kukushkin, V. Y.; Haukka, M.; Pombeiro, A. J. L. A Route to 1,2,4-Oxadiazoles and Their Complexes via Platinum-Mediated 1,3-Dipolar Cycloaddition of Nitrile Oxides to Organonitriles. Inorg. Chem. 2003, 42, 896–903. DOI 10.1021/ic026103v
   PubMed Web of Science ®Google Scholar
• dos Santos Filho, J. M.; Leite, A. C. L.; de Oliveira, B. G.; Moreira, D. R. M.; Lima, M. S.; Soares, M. B. P.; Leite, L. F. C. C. Design, Synthesis and Cruzain Docking of 3-(4-Substituted-Aryl)-1,2,4-oxadiazole-N-Acylhydrazones as anti-Trypanosoma Cruzi Agents. Bioorg. Med. Chem. 2009, 17, 6682–6691. DOI 10.1016/j.bmc.2009.07.068
   PubMed Web of Science ®Google Scholar
• Burns, A. R.; Kerr, J. H.; Kerr, W. J.; Passmore, J.; Paterson, L. C.; Watson, A. J. B. Tuned Methods for Conjugate Addition to a Vinyl Oxadiazole; Synthesis of Pharmaceutically Important Motifs. Org. Biomol. Chem. 2010, 8, 2777–2783. DOI 10.1039/c001772h
   PubMed Web of Science ®Google Scholar
• Kiss, L. E.; Ferreira, H. S.; Torrao, L.; Bonifacio, M. J.; Palma, P. N.; Soares-da-Silva, P.; Learmonth, D. A. Discovery of a Long-Acting, Peripherally Selective Inhibitor of catechol-O-Methyltransferase. J. Med. Chem. 2010, 53, 3396–3411. DOI 10.1021/jm1001524
   PubMed Web of Science ®Google Scholar
• Jeschke, P.; Wachendorff-Neumann, U.; Erdelen, C.; Mencke, N.; Turberg, A. Ger. Offen. DE 1995, 4, 401–107. Cl.C07D271/06), 20 Jul 1995, Appl. 17 Jan 1994, 40pp; Chem Abstr. 123, 340135t
   Google Scholar
• Carbone, M.; Li, Y.; Irace, C.; Mollo, E.; Castelluccio, F.; Di Pascale, A.; Cimino, G.; Santamaria, R.; Guo, Y.; Gavagnin, M. Structure and Cytotoxicity of Phidianidines a and B: First Finding of 1,2,4-Oxadiazole System in a Marine Natural Product. Org. Lett. 2011, 13, 2516–2519. DOI 10.1021/ol200234r
   PubMed Web of Science ®Google Scholar
• Balaraju, T.; Kumar, A.; Bal, C.; Chattopadhyay, D.; Jena, N.; Bal, N. C.; Sharon, A. Aromatic Interaction Profile to Understand the Molecular Basis of Raltegravir Resistance. Struct. Chem. 2013, 24, 1499–1512. DOI 10.1007/s11224-012-0181-1
   Web of Science ®Google Scholar
• Thiyagarajan, A.; Salim, M. T.; Balaraju, T.; Bal, C.; Baba, M.; Sharon, A. Structure Based Medicinal Chemistry Approach to Develop 4-Methyl-7-Deazaadenine Carbocyclic Nucleosides as anti-HCV Agent. Bioorg. Med. Chem. Lett. 2012, 22, 7742–7747. DOI 10.1016/j.bmcl.2012.09.072
   PubMed Web of Science ®Google Scholar
• Kasula, M.; Balaraju, T.; Toyama, M.; Thiyagarajan, A.; Bal, C.; Baba, M.; Sharon, A. A Conformational Mimetic Approach for the Synthesis of Carbocyclic Nucleosides as anti-HCV Leads. ChemMedChem. 2013, 8, 1673–1680. doi:10.1002/cmdc.201300277
   PubMed Web of Science ®Google Scholar
• Genheden, S.; Ryde, U. The MM/PBSA and MM/GBSA Methods to Estimate Ligand-Binding Affinities. Expert Opin. Drug. Discov. 2015, 10, 449–461. DOI 10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Li, J.; Abel, R.; Zhu, K.; Cao, Y.; Zhao, S.; Friesner, R. A. The VSGB 2.0 Model: A Next Generation Energy Model for High Resolution Protein Structure Modeling. Proteins Struct. Funct. Bioinf. 2011, 79, 2794–2812. DOI 10.1002/prot.23106
   PubMed Web of Science ®Google Scholar